DK0779075T3 - Anvendelse af 3-alpha-hydroxy-5-alpha-androsta-16-en som lægemidler - Google Patents

Anvendelse af 3-alpha-hydroxy-5-alpha-androsta-16-en som lægemidler

Info

Publication number
DK0779075T3
DK0779075T3 DK96402710T DK96402710T DK0779075T3 DK 0779075 T3 DK0779075 T3 DK 0779075T3 DK 96402710 T DK96402710 T DK 96402710T DK 96402710 T DK96402710 T DK 96402710T DK 0779075 T3 DK0779075 T3 DK 0779075T3
Authority
DK
Denmark
Prior art keywords
alpha
androsta
ene
hydroxy
drugs
Prior art date
Application number
DK96402710T
Other languages
English (en)
Inventor
Daniel Philibert
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK0779075T3 publication Critical patent/DK0779075T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK96402710T 1995-12-13 1996-12-12 Anvendelse af 3-alpha-hydroxy-5-alpha-androsta-16-en som lægemidler DK0779075T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9514750A FR2742337B1 (fr) 1995-12-13 1995-12-13 Application du 3-alpha-hydroxy-5-alpha-androsta-16-ene a titre de medicaments

Publications (1)

Publication Number Publication Date
DK0779075T3 true DK0779075T3 (da) 2002-02-18

Family

ID=9485442

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96402710T DK0779075T3 (da) 1995-12-13 1996-12-12 Anvendelse af 3-alpha-hydroxy-5-alpha-androsta-16-en som lægemidler

Country Status (9)

Country Link
US (1) US5696107A (da)
EP (1) EP0779075B1 (da)
JP (1) JPH09176183A (da)
AT (1) ATE207750T1 (da)
DE (1) DE69616484T2 (da)
DK (1) DK0779075T3 (da)
ES (1) ES2162992T3 (da)
FR (1) FR2742337B1 (da)
PT (1) PT779075E (da)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR676202A (fr) * 1928-06-06 1930-02-20 Serrure à pène applicable aux portes fermant à gauche et à droite
JPS62501909A (ja) * 1985-01-25 1987-07-30 モネル　ケミカル　センシス　センタ− ヒト女性における黄体期不全及び無排卵を治療する為のアンドロステノ−ル及び硫酸デヒドロエピアンドロステロンを含む男性エッセンスの使用
US5155045A (en) * 1985-01-25 1992-10-13 Trustees Of The University Of Penn. Use of male essence to alter female endocrine response
JPH01115892A (ja) * 1987-10-29 1989-05-09 Mitsubishi Electric Corp 液相成長装置
US5272134A (en) * 1992-03-24 1993-12-21 Erox Corporation Fragrance compositions and other compositions which contain human pheromones
FR2717690B1 (fr) * 1994-03-24 1996-04-26 Roussel Uclaf Application de stéroïdes aromatiques 3 substitués par un aminoalcoxy substitué à l'obtention d'un médicament pour contrôler la stérilité, notamment masculine.
WO1996036230A1 (en) * 1995-05-16 1996-11-21 The Salk Institute For Biological Studies Modulators for new members of the steroid/thyroid superfamily of receptors

Also Published As

Publication number Publication date
DE69616484T2 (de) 2002-04-04
FR2742337A1 (fr) 1997-06-20
FR2742337B1 (fr) 1998-03-06
JPH09176183A (ja) 1997-07-08
PT779075E (pt) 2002-04-29
DE69616484D1 (de) 2001-12-06
US5696107A (en) 1997-12-09
ATE207750T1 (de) 2001-11-15
ES2162992T3 (es) 2002-01-16
EP0779075A1 (fr) 1997-06-18
EP0779075B1 (fr) 2001-10-31

Similar Documents

Publication Publication Date Title
AR038431A2 (es) Derivados 2-desoxo-15-alquilo de marcfortina
DE19681287T1 (de) Orale Formulierung von 2-Methylthienobenzodiazepin
MX9205981A (es) Administracion transdermica de melatonina.
FI931250A0 (fi) Sulfonamido- och sulfonamidokarbonyl-pyridin-2-karboxylsyraamider och deras pyridin-n-oxider, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
KR950700754A (ko) 신규의 약물(novel medicament)
ES2095432T3 (es) Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES1022219Y (es) "ambientador de sobremesa"
FI941396A0 (fi) Koostumuksia biologisesti aktiivisen TGF-valvottua vapauttamista varten
TR199701654T1 (xx) 4-Fenilaminotiyazol t�revleri.
IT1285770B1 (it) Composti corticoidei
ES2102475T3 (es) Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
FI925633L (fi) Foerfarande foer framstaellning av en farmaceutisk sammansaettning som selektivt saenker lipidnivaon i blodet
ES2107284T3 (es) Nuevas n-piridil-carboxamidas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2091310T3 (es) Nuevos derivados de la n-benzoil-prolina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2160308T3 (es) Nuevos derivados amino-metil-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2125963T3 (es) Nuevos derivados espiranicos del 3-amino-cromano, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
TR27833A (tr) Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu.
IT1270905B (it) Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
TR199701298T1 (xx) Tetralinler.
FR2710539B1 (fr) Ensemble d'aiguille chirurgicale.
UY24915A1 (es) Derivados de benzoxazindiona, aplicación de los mismos y medicamentos que los contienen
DK0579939T3 (da) Phospholipidderivater
ES2162986T3 (es) Derivados de mercapto-alcanoil-dipeptidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2091570T3 (es) Nuevos derivados peptidicos antagonistas de la bradiquidina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2095714T3 (es) Nuevas amino-alquil-cromonas, sus procedimientos de preparacion y las composiciones farmaceuticas que las contienen.